Specialty Outpatient Care for Pediatric Anxiety & OCD

Inc. Names InStride Co-Founders Dr. Mona Potter and Dr. Kathryn Boger to Its 2026 Female Founders 500 List

Inc.’s annual Female Founders list celebrates the nation’s most innovative women entrepreneurs, who collectively generated approximately $12.3 billion in 2025

BOSTON, March 10, 2026 – InStride Health, a leading insurance-based provider of specialty anxiety and obsessive-compulsive disorder (OCD) treatment for children, adolescents and young adults, is proud to announce that Dr. Mona Potter, Chief Medical Officer and Dr. Kathryn Boger, Chief Clinical Officer have been named to Inc.’s 2026 Female Founders 500, an annual list honoring the most dynamic women business leaders in the United States. The honor recognizes founders whose bold ideas, resilience, and execution are shaping the future of their industries. The 2026 Female Founders honorees collectively generated approximately $12.3 billion in 2025 revenue and $12.2 billion in funding to date, underscoring the economic impact of women-led businesses across sectors.

Each year, Inc. editors evaluate applications through a rigorous, multi-round selection process. Founders are assessed on both quantitative performance metrics, including revenue growth, funding, sales, and audience size, as well as qualitative factors such as innovation, social impact, and brand momentum. The final list represents entrepreneurs who have demonstrated exceptional leadership and measurable progress over the past year. Previous honorees have included such game-changing leaders as Billie Jean King, Sallie Krawcheck, Serena Williams, and Emma Grede — all of whom have transformed their industries and broken barriers along the way.

"When we founded InStride, our mission was simple but urgent: ensure today’s youth struggling with anxiety and OCD have access to evidence-based care without barriers like waitlists, geography or finances,” said Dr. Potter. “This recognition reflects the extraordinary clinicians, families, and partners who share that commitment every day, and the work we’re continuing together to expand access to high-quality specialty mental healthcare for families."

Honoree selection is honed through the evaluation of the program’s advisory board, which includes Patty Arvielo, co-founder and CEO of New American Funding; Tiffany Dufu, president of the Tory Burch Foundation; Joy Mangano, co-founder and CEO of CleanBoss; Michelle Cordeiro Grant, founder and CEO of GORGIE; Sheila Lirio Marcelo, co-founder and CEO of Ohai.ai and founder of Care.com; and Melissa Mash, co-founder and CEO of Dagne Dover.  

“This recognition reflects the impact InStride is having by putting the young people we serve and their families at the center of everything we do while maintaining the highest standards of clinical rigor,” said Dr. Boger. “From the beginning, we set out to build a care model that combines deep clinical expertise with a collaborative team approach so young people and families can make meaningful progress quickly. Being recognized alongside my co-founder makes this especially meaningful. It’s a testament to what we’ve built together with our team and to the work still ahead to expand access to effective mental health care.”

InStride Health’s evidence-based, multidisciplinary care model provides families with insurance-covered care that delivers consistently strong clinical outcomes, helping them get their lives back. The company’s most recent outcomes data show that 98% of program graduates experienced overall improvement compared to baseline, with 9 out of 10 reporting significant reductions in anxiety symptoms as early as two months.

"Each year, we are increasingly amazed by the extraordinary leaders on our Inc. Female Founders 500 list,” says Bonny Ghosh, editorial director at Inc. “The honorees on this year’s list include innovators in AI, beauty and wellness trendsetters winning devoted fans, and nonprofit leaders making a real impact in their communities. Together, they’re showing all of us what trailblazing female leadership looks like.”

Several honorees will be featured in Inc. magazine’s Spring print issue, on newsstands March 17, 2026. To learn more about InStride Health, visit https://instride.health/.
 

About Inc.

Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit www.inc.com.
 

InStride Health

InStride Health provides specialty outpatient care for pediatric anxiety, Obsessive-Compulsive Disorder (OCD), and related presentations. Co-founded by Harvard-trained clinicians, the InStride Health care model is grounded in evidence-based treatment, specifically cognitive behavioral therapy (CBT) with an emphasis on exposure therapy. Each young person is paired with a dedicated, multidisciplinary team of a psychiatrist, therapist, and an exposure coach that helps both the young person and their family. The young person is provided with real-time support as they face their fears and develop skills and strategies for lasting change. InStride Health accepts most major insurance plans and is accepting patients in Connecticut, Illinois, Maine, Massachusetts, New Hampshire, New Jersey, New York, Ohio, Pennsylvania, Rhode Island, Texas, Virginia and Washington D.C.     
 

Media Contact:

Matt Miller V2 Communications Instride@v2comms.com

Talk to Us

Have a question about InStride Health? We're here to help.

For Families and General Inquiry:
Phone: 855.438.8331
Email: info@instride.health

For Providers:
Phone: 855.438.8331
Email: providersupport@instride.health